Patents Assigned to Asteroid Therapeutics
  • Patent number: 12454547
    Abstract: The invention describes novel steroidal compounds, compositions containing the same, and methods of using the same as SREBP inhibitors, as LXR agonists, or as dual modulators of SREBP and LXR, to treat SREBP and/or LXR mediated diseases.
    Type: Grant
    Filed: April 22, 2023
    Date of Patent: October 28, 2025
    Assignee: Asteroid Therapeutics
    Inventors: Antonio Feula, Francesco G Salituro, Ryan Edward Stites